- Reaction score
- 42
alfie said:peloncete1989 said:Sorry, who has said that RU inhibits 70% of DHT?
And where is this info available?
Thanks guys.
RU58841/PSK-3841: Phase II
A topical, non-steroidal androgen antagonist, PSK-3841 (formerly HMR-3841 and RU-58841), is being investigated in France by Proskelia for possible therapeutic value in Androgenetic Alopecia and acne [102,104]. The compound was in Phase II clinical trials as of January 2004 [102,105], and was originally researched by Roussel-Uclaf and Hoechst Marion Roussel [102]. PSK-3841 is an androgen receptor (AR) inhibitor capable of blocking 70% of DHT binding [18]. When compared with the antiandrogenic compound cyproterone acetate, PSK-3841 exhibited a 20% increase in AR binding [18].
Please cite the actual study where such a claim is made (the study number is "18", by the way).